Posted in | News | Mining Business

Ascot Extends Premier and Dilworth Option Agreements

Ascot Resources Ltd (the "Company" or "Ascot") is pleased to announce that it has entered into amending agreements extending its Premier and Dilworth option agreements until December 30, 2015. The revised agreements call for combined option payments of $900,000 on each of December 30, 2013 and 2014 and a final option payment of $13,700,000 on December 30 2015.

In addition the optionors will receive an additional 5% Net Smelter Royalty which can be bought out any time after December 31, 2015 for $13,700,000.

Ascot announces that, subject to regulatory approval, it will undertake a non-brokered private placement to accredited investors of up to 6,666,667 flow through units (the "Flow Through Units"), at a price of $0.75 per Flow Through Unit for gross proceeds of approximately $5 million. Each Flow Through Unit will consist of one flow through share and one non-transferable, flow through share purchase warrant. Each warrant will be exercisable for an additional flow through share for a period of one year from the closing of the private placement at an exercise price of $0.75 per flow through share.

Ascot will also, subject to regulatory approval, undertake a non-brokered private placement to accredited investors of up to 6,666,667 units (the "Units) at a price of $0.75 per Unit for gross proceeds of approximately $5 million. Each Unit will consist of one share and one non-transferable unit, exercisable at a price of $0.75 for a period of one year from the closing of the private placement. Each non-transferable unit will consist of a common share and a warrant. Each warrant will be exercisable for an additional common share for a period of two years from the original closing of the private placement at an exercise price of $0.85.

All securities issued pursuant to the private placements will be subject to a four month hold period.

In connection with the private placements the Company will pay, subject to TSX Venture Exchange approval, a cash fee of 7.5% per cent of the gross proceeds raised by finders and issue non- transferable warrants equal to 7.5% of the Units and Flow Through Units sold pursuant to the efforts of finders. The Finder's Warrants will be exercisable at $0.75 per Finder's Warrant into common shares of the Company for a period of one year from the closing of the private placement.

The flow through funds raised from the flow through private placement will be used for exploring the Company's Premier and Dilworth properties which will constitute Canadian exploration expenses.

The Company anticipates resuming drilling at Premier/Dilworth immediately. Emphasis for 2013 will be on following up high grade zones encountered in previous years' drilling.

ON BEHALF OF THE BOARD OF DIRECTORS OF
ASCOT RESOURCES LTD.
"John A. Toffan", President and Director

Source: http://www.ascotresources.ca/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ascot Resources Ltd.. (2019, February 17). Ascot Extends Premier and Dilworth Option Agreements. AZoMining. Retrieved on April 26, 2024 from https://www.azomining.com/News.aspx?newsID=8477.

  • MLA

    Ascot Resources Ltd.. "Ascot Extends Premier and Dilworth Option Agreements". AZoMining. 26 April 2024. <https://www.azomining.com/News.aspx?newsID=8477>.

  • Chicago

    Ascot Resources Ltd.. "Ascot Extends Premier and Dilworth Option Agreements". AZoMining. https://www.azomining.com/News.aspx?newsID=8477. (accessed April 26, 2024).

  • Harvard

    Ascot Resources Ltd.. 2019. Ascot Extends Premier and Dilworth Option Agreements. AZoMining, viewed 26 April 2024, https://www.azomining.com/News.aspx?newsID=8477.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.